Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.

Support Care Cancer · 2016 · PMC4917578 · PMID 27005463

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

1 a, the increase in LBM from baseline was significantly greater in the 100-mg anamorelin group at weeks 8 and 12 than in the placebo group, although the LS mean change from baseline to week 12 was of borderline significance.

also in 1,681 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.